AndrewDCampbellMD
Pediatric Hematology & Oncology • Washington, DCMedical Director, Sickle Cell Program, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC Associate Professor of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC
Dr. Campbell is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Children's National Medical Center
111 Michigan Avenue
Washington, DC 20010Phone(202) 476-2800
Fax(202) 476-5685- Is this information wrong?
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 1999 - 2002
Massachusetts General HospitalResidency, Pediatrics, 1996 - 1999
Case Western Reserve University School of MedicineClass of 1996
Certifications & Licensure
VA State Medical License 2020 - 2022
DC State Medical License 2017 - 2022
MD State Medical License 2017 - 2022
MI State Medical License 2002 - 2018
IL State Medical License 1999 - 2005- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top Doctors Castle Connolly Medical LTD, 2018
- 2018 Best Doctors in America, Pediatric Hematology/Oncology Best Doctors Inc., 2013-2018
Clinical Trials
- Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease Start of enrollment: 2016 May 01Josh Lehrer-Graiwer, MD
- Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias Start of enrollment: 2014 Mar 01Almomen, A.,Alshehri, A.,Beshlawy, A.E.,Campbell, A.,Inusa, B.,Aygun, B.,Kaya, B.,Fradette, C.,Bittar, C.,Lobo, C.,Pulte, D.,Vichinsky, E.,Kwiatkowski, J.,Kantor, J.,Figueiredo, M.S.,Badr, M.,Elsafy, M.,Q...
- A Phase II Study of Hematopoietic Stem Cell Therapy for Young Adults With Severe Sickle Cell Disease Start of enrollment: 2012 Mar 01Abraham, A.,Wiedl, C.,Bascon, C.,Pantin, J.,Candler, K.,Sullivan, K.,Krishnamurti, L.,Prosser, L.,Lekakis, L.J.,Wells, L.,Walters, M.C.,Byrne, M.A.,Gonzalez, N.,Young, R.,Gerkin, R.,Murray, S.
- A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
- Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients Novartis Pharmaceuticals
Publications & Presentations
PubMed
- An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Re...Andrew D. Campbell, Raffaella Colombatti, Biree Andemariam, Crawford John Strunk, Immacolata Tartaglione, Connie M. Piccone, Deepa Manwani, Eugenia Vicky Asare, Donna ...> ;Journal of racial and ethnic health disparities. 2021 Feb 1
- A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analy...Charles Antwi-Boasiako, Biree Andemariam, Raffaella Colombatti, Eugenia Vicky Asare, Crawford John Strunk, Connie M. Piccone, Deepa Manwani, Donna Boruchov, Fatimah Fa...> ;Annals of Hematology. 2020 May 6
- Serum Iron Levels and Copper-to-Zinc Ratio in Sickle Cell DiseaseCharles Antwi-Boasiako, Gifty B. Dankwah, Robert Aryee, Charles Hayfron-Benjamin, Alfred Doku, Benoit Banga N’guessan, Isaac Julius Asiedu-Gyekye, Andrew D. Campbell> ;Medicina-buenos Aires. 2019 May 21
- Join now to see all
Journal Articles
- Low nitric oxide level is implicated in sickle cell disease and its complications in GhanaAntwi-Boasiako C, Campbell AD, Vascular Health and Risk Management, 9/6/2018
Abstracts/Posters
- Economic Burden of End Organ Damage Among Patients with Sickle Cell Disease in the USAndrew D. Campbell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- An Analysis of Racial and Ethnic Backgrounds within the Casire International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Re...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Outcomes in Children with Severe Vasculopathy from Sickle Cell Anemia after Treatment with Chronic Transfusion, Surgical Revascularization and/or Allogenic Hematopoeti...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Potential Treatment for Sickle Cell DiseaseNovember 10th, 2011
Professional Memberships
- Member
Hospital Affiliations
Children's National HospitalWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
